Linyan Xu

Phase II trial of co‐administration of CD19‐ and CD20‐targeted chimeric antigen receptor T cells for relapsed and refractory diffuse large B cell lymphoma

Wei Sang, Ming Shi, Jing‐Jing Yang et al. · Cancer Medicine · 2020 · 78 citations · Full text

Medicine, Hematology, Oncology +16

The arginine methyltransferase PRMT5 and PRMT1 distinctly regulate the degradation of anti-apoptotic protein CFLARL in human lung cancer cells

Mingyue Li, Wentao An, Linyan Xu et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 52 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Risk factors of mild cognitive impairment in middle aged patients with type 2 diabetes: A cross–section study

Ruihua Chen, Xiaozhen Jiang, Xiaohui Zhao et al. · Annales d Endocrinologie · 2012 · 51 citations

Medicine, Geriatric Medicine, Neurology +15

PKCδ Regulates Death Receptor 5 Expression Induced by PS-341 through ATF4–ATF3/CHOP Axis in Human Lung Cancer Cells

Linyan Xu, Ling Su, Liu X · Molecular Cancer Therapeutics · 2012 · 50 citations

Life Sciences, Molecular Biology, Oncology +17

Assembly of Silver(I)/N,N-Bis(diphenylphosphanylmethyl)-3-aminopyridine/Halide or Pseudohalide Complexes for Efficient Photocatalytic Degradation of Organic Dyes in Water

Chunyu Liu, Linyan Xu, Zhi‐Gang Ren et al. · Crystal Growth & Design · 2017 · 45 citations

Natural Sciences, Chemistry, Materials Science +17